FAES Farma SA operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares FAES Farma SA with three other
pharmaceutical manufacturers in Europe:
Produits Chimiques Auxiliares et de Synthese
sales of 179.09 million Euro [US$196.58 million]
of which 67%
was Pharmaceutical Synthesis),
Dechra Pharmaceuticals PLC
of the United Kingdom
(£203.48 million [US$249.98 million]
of which 83%
was European Pharmaceuticals), and
based in Germany
(229.73 million Euro [US$252.17 million]
FAES Farma SA reported sales of 204.72 million Euro (US$224.72 million)
December of 2015.
increase of 6.8%
versus 2014, when the company's sales were 191.74 million Euro.
This was the third consecutive year of growth at FAES Farma SA.
The sales level in 2015 was fairly close to the level five years ago: in 2010, FAES Farma SA had sales
of 202.51 million Euro.
Sales of Specialty Pharmaceuticals saw an increase
that was more than double the company's growth rate: sales were up
15.0% in 2015, from
151.53 million Euro to 174.19 million Euro.
Not all segments of FAES Farma SA experienced an increase in sales in 2015:
sales of Other fell 24.1% to 30.54 million Euro.